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A considerable literature has evolved over the last 10 years concerned with the infective complications of therapeutic immunosuppression, largely as a result of advances in renal and other organ transplantation and developments in cancer chemotherapy. It became apparent at an early stage that opportunist infection was one of the major complications of these procedures and indeed, infection was, and remains, the single commonest cause of death (Chang et al. 1976 , Simmons et al. 1975 , Jamieson et al. 1979 . Much has subsequently been learnt about the epidemiology of infection in these patients, and considerable progress has been made in both prophylaxis and treatment. There exists, however, a large population of immunosuppressed patients who have received far less attention, and it is this groupthose with immunologically-mediated diseases -who are the subject of this review.
Immunologically-mediated diseases can be conveniently divided into two groups: conditions such as systemic lupus erythematosus (SLE) and mixed essential cryoglobulinaemia, in which circulating immune complexes are thought to play a pathogenetic role; and others (e.g. antiglomerular basement membrane antibody (anti-GBM) disease and myasthenia gravis) in which there is antibody-mediated immune injury. The recognition of the role of these pathogenetic mechanisms led naturally to trials of various forms of immunosuppressive therapy with agents such as corticosteroids, cyclophosphamide, azathioprine and plasma exchange (Hodgson 1981) . The immunosuppression thus produced led inevitably to opportunist infection. Are there any differences between the infective problems encountered in patients such as these compared to patients with leukaemia or transplant recipients?
Infective complications of therapeutic immunosuppression
Host response
One of the factors that distinguishes this group of patients with immunologically-mediated disease is that their disease reflects an underlying disorder of immunity which might itself influence the host response to infection. SLE is most frequently cited as an example, but there is considerable debate as to whether any such influence is clinically significant.
Although it is often stated that patients with SLE are more prone to infection, it is difficult to separate the influence of the disease itself from the effects of the immunosuppressive therapy, usually corticosteroids. Staples et al. (1974) studied 23 patients with SLE and compared their infection rate with control groups of patients with rheumatoid arthritis and nephrotic syndrome. Overall, the infection rate in the SLE group was higher than in the controls, but when patients were grouped according to dose of steroids, statistical significance was achieved only in those receiving less than 20 mg of prednisolone daily. These data need to be interpreted cautiously: the number of patients is small, and the controls were not age or sex matched. Nevertheless, Staples and his colleagues concluded that SLE did predispose to infection, and that high-dose corticosteroids enhanced that susceptibility. Some support for this view comes from a prospective computer analysis of 223 patient with SLE (Ginzler et al. 1978) , which confirmed that the infection rate increased pari passu with increasing steroid dose. These data do not reveal whether SLE itself predisposes to infection, but active renal disease was associated with an increase in the frequency of infection, independent of the steroid dose. Lee et al. (1977) reported their experience of 100 patients with SLE studied for 4~years. All 26 patients who became infected were receiving steroids, but the mean maintenance dose of prednisolone received by these patients (17.0 mg daily) was not significantly different from the dose received by non-infected patients (15.4 mg). However, the mean steroid dose of the 12 patients with serious infection was significantly greater (59.0 mg). Of some interest was the observation that SLE disease activity was greater in the septic compared to the non-infected patients. Lee took this to mean that active disease predisposed to infection; the alternative hypothesis -that infection can exacerbate the severity of the disease -is discussed below.
Although most clinicians experienced in the management of SLE feel that the disease does predispose to infection, objective data to confirm this are lacking. What does seem clear is that major life-threatening infections that occur in SLE are almost always seen in patients with active disease who require high-dose corticosteroids.
Other conditions in which there is evidence of enhanced susceptibility to infection are rheumatoid arthritis, in which defective phagocytic activity of synovial fluid polymorphs leads to an increased incidence of septic arthritis (Bodel & Hollingsworth 1966) , and Felty's syndrome of rheumatoid arthritis, splenomegaly and granulocytopenia. Recurrent infection formed part of the original description (Felty 1924) , though interestingly the frequency of pyogenic infections is not directly correlated with the degree of granulocytopenia, and despite a number of attempts to demonstrate a functional granulocyte defect (Zivkovic & Baum 1972 , Gupta et al. 1976 ) no convincing explanation has been found.
Uraemia is known to affect host response, and renal involvement is a common feature of many immunologically-mediated diseases. There is considerable experimental evidence to indicate that uraemia has an immunosuppressive effect, and indeed infection is a major problem in the management of patients with renal disease (Montgomerie et al. 1968 ). The cause of this immunosuppression is, however, less clear. The best evidence is of delayed homograft rejection (Dammin et al. 1957) , but the precise cellular mechanisms which are responsible are unknown. In vitro data of T lymphocyte function in uraemia are conflicting, and the results are highly dependent on experimental design (Miller & Stewart 1980a,b) . Uraemia per se does not seem to affect significantly humoral immunity or complement function, although these may be abnormal in patients on haemodialysis (Goldblum & Reed 1980) .
The balance of evidence is that uraemia does play a contributory role in depressing cellular immune function, but the clinical effect is usually swamped by the concurrent therapeutic immunosuppression.
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In general, patients with immunologically-mediated diseases suffer similar infections to those of other groups of patients receiving therapeutic immunosuppression. It is commonly held that the pattern of infection in immunosuppressed patients can be predicted from a knowledge of the underlying immune defect (Durack 1982) , and it is undoubtedly true that children with primary immunodeficiency syndromes do demonstrate a clear-cut relationship between the nature of their immune defect and the infective complications that they suffer (Di George 1968 , Good et al. 1962 . In attempting to demonstrate similar patterns in adults with acquired, therapeutic immunosuppression, most authors have usually failed to present denominator data when comparing infection rates in different populations (Young 1981) . To overcome this we recently carried out a retrospective analysis of 2500 patients with SLE, Hodgkin's disease, non-Hodgkin's lymphoma, leukaemia, and renal transplant recipients, in which we were able to" obtain adequate denominator data (Cohen & Durack 1983) . In these patients, as well as those other groups described above, bacteria accounted for approximately 75% of all infections. Fungi and viruses each contributed about 10%, while the 'exotic' opportunist pathogens (e.g. Toxoplasma, Pneumocystis) were seen in only about 5% of instances. However, comparison between the diagnostic groups showed no clear patterns analogous to those seen in children with primary immunodeficiency, the most . striking exception being an excess of varicella zoster infections in Hodgkin's disease, confirming previous studies (Sokal & Firat 1965) . There are certainly problems in interpreting retrospective analyses of this kind, but it appears that the practice of predicting causes of infection based on the underlying immunological defect alone is probably unreliable. It seems more likely that patients who have been in hospital for some time and been subjected to various 'invasive' procedures likely to breach host defences (urinary catheterization, intravenous cannulae, prolonged courses of antibiotics, etc.), enter a 'final common pathway' of susceptibility to infection in which various defects of host defence merge to produce a rather similar pattern of infection. Nevertheless, certain differences do exist. For example, patients with granulocytopenia « 500/mm 3 ) suffer frequently with Gram-negative bacteraemia, and Pseudomonas aeruginosa is seen more often than in the non-neutropenic host. In contrast, Streptococcus faecalis is a common pathogen in renal transplant recipients but is only rarely encountered in leukaemics. In patients with leukaemia, septicaemia, perianal and catheter-associated infections are common. In renal transplants, the urinary tract or surgical wounds are the commonly infected sites. In those with immunologically-mediated diseases, we found the upper and lower respiratory tract and the urinary tract to be most frequently involved (reflecting the common sites of active underlying disease), and also noted problems with vascular access sites for haemodialysis or plasma exchange (Cohen et al. 1982) .
C:onsequences of therapy
There are a number of differences between the type of immunosuppression used in immunologically-mediated diseases and the regimens employed in leukaemia or bone marrow transplantation. Remission induction in leukaemia and preparation for bone marrow transplantation usually involve considerable marrow depression amounting to virtual aplasia. Agents which are commonly used are cyclophosphamide, methotrexate, procarbazine, antilymphocyte globulin and total body irradiation (Harris 1981) . In the immunologically-mediated diseases the common immunosuppressive agents are prednisolone (usually in rather lower doses than following renal transplantation), cyclophosphamide, azathioprine, and sometimes plasma exchange (Rees & Lockwood 1982) . Although much is known about the mechanisms of immunosuppression brought about by these agents (for review see Rees & Lockwood 1982) , in clinical practice they are generally given in combination, which makes it difficult to assess their individual contribution to the risk of infection.
Corticosteroids are both anti-inflammatory and immunosuppressive. It is well recognized that the clinical signs of inflammation may be 'masked' in patients receiving steroids, resulting in considerable diagnostic difficulties. In addition, there is little doubt that prolonged high-dose corticosteroids do increase susceptibility to infection (Dale & Petersdorf 1973) . Unfortunately, there are no data which give a clear indication of the degree of increased risk, the length of time after which risk increases significantly, the relationship between dose and infective risk, or the particular type of infection that is likely to occur.
Even less is known about the risk of infection due to other immunosuppressive drugs. There is some evidence that azathioprine itself does not lead to increased risk of infection (Haynes 1978) and that, like cyclophosphamide, infection is most often a result of the attendant neutropenia rather than the pharmacological consequences of immunosuppression per se (Cohen et al. 1982) .
Plasma exchange is a method of immunosuppression which has been found to have particular use in patients with immunologically-mediated disease. The procedure has a profound effect on humoral defence mechanisms (antibody and complement) and may also affect lymphocytes (Hersey et al. 1976 ) and mononuclear phagocytes (Lockwood et al. 1979) . It has been suggested (Wing et al. 1980 ) that plasma exchange leads to enhanced susceptibility to infection. Our own experience is to the contrary: we found no evidence of Journal of the Royal Society of Medicine Volume 76 June 1983 5lJ increased risk, even in patients who received 10 or more consecutive daily exchanges (Cohen et al. 1982) .
Granulocytopenia occurs infrequently in patients receiving immunosuppressive therapy for immunologically-mediated diseases, and this has a major influence on the frequency of infection. It is known that a granulocyte count of less than 500/mm 3 (and in particular less than 100/mm 3 ) results in a significant and highly predictable susceptibility to septicaemia, usually with Gram-negative organisms such as Escherichia coli, Klebsiella and Pseudomonas aeruginosa (Bodey et al.. 1966) . Such a profound degree of leukopenia is only an occasional complication of the chemotherapy used in patients with immunologically-mediated disease, although we have noted that in this setting even a white cell count of less than 2000/mm 3 may significantly increase the risk of infection (Cohen et al. 1982) .
One of the most difficult problems in the management of the neutropenic leukaemic patient are the frequent episodes of high fever for which no microbiological explanation can be found. Disagreements about the correct management of these episodes have resulted in much controversy and many clinical trials, but the information obtained from these studies in leukaemia cannot be applied to patients with immunologically-mediated disease. For instance, Stahl et al. (1979) examined the causes of 83 episodes of fever in 63 hospitalized patients with SLE, and found that only 19 (23%) were due to infection. Other causes were disease activity, drug fever, and myocardial infarction; only 6 (7%) could not be explained, except as 'post-surgical fever'. This is in marked contrast to fevers in leukaemia, for example, in which 30% of episodes are unexplained, and 65% are due to infection (Bodey et al. 1978) . The presence of a normal white cell count is thus a major factor which distinguishes patients with immunologically-mediated disease from other groups of immunosuppressed patients.
Immunological consequences of infection
The preceding section has been concerned with the infective consequences of immunosuppression, but it is becoming increasingly clear that this relationship is not all one-sided, and that infection itself can interact with immunological mediators and influence the underlying disease. This phenomenon, which has been called 'infection-provoked relapse', has been described in several immunologically-mediated diseases. Rees et al. (1977) described 7 patients with typical anti-GBM disease in whom relapse was diagnosed on 16 occasions. In only one case was relapse associated with a rising titre of anti-GBM antibodies. Thirteen of the remaining IS episodes were preceded (within 24 hours) by bacterial infection.
Similarly, Pinching et al. (1980) reported on 20 relapses in 18 patients with Wegener's granulomatosis. Nine episodes appeared to be provoked by bacterial or viral infection. These authors noted that treatment of the infection alone was usually inadequate to reverse the relapse, and that improvement required combined antimicrobial and immunosuppressive therapy.
These studies and similar experience in SLE and cryoglobulinaemia emphasize the importance of screening for infection all such patients who present in relapse. Of more fundamental interest is the nature of the immunopathogenetic mechanisms responsible for this phenomenon. There are a number of possible explanations:
(I) Infection may amplify the immune injury caused by the underlying disease. This seems unlikely, since infections which provoked relapse in anti-GBM disease were not accompanied by a rise in anti-GBM antibodies (Rees et al. 1977) .
(2) Infection may generate an 'acute phase response' of proteins, such as C3, fibrinogen and C-reactive protein, which' then serve as mediators for immune injury. Limited experimental data (see below) suggest that this is not an important mechanism.
(3) Polymorphonuclear leukocytes playa central role in glomerular injury in animal models of anti-GBM nephritis (Cochrane et al. 1965) , and it is conceivable that infection induces a quantitative and/or qualitative change in neutrophils which leads to tissue damage. Certainly there is no clear association simply with the total number of neutrophils, although it remains possible that there are more subtle effects on localization or neutrophil function.
(4) Circulating immune complexes are another potential candidate. They did appear to be important in the patients with Wegener's granulomatosis (Pinching et al. 1980) , although not in the anti-G BM series (Rees et al. 1977) .
(5) Mononuclear phagocytes merit serious consideration. Infection has a profound effect on macrophage function (Allison 1982) and some experimental evidence suggests that they may be implicated. For example, Watson et al. (1965) were able to enhance heterologous injury in nephrotoxic nephritis by pretreatment with Freund's complete adjuvant, a potent stimulus to macrophage activation.
In an attempt to answer some of these questions, an experimental model of infectionenhanced injury was developed (Rees 1979) , based on a modified rabbit nephrotoxic nephritis system and using a mixture of Staph. aureus and croton oil as the stimulus. Renal injury (as evidenced by proteinuria) was significantly increased in the stimulated compared to control animals. However, no association could be demonstrated between enhanced injury and serological or immunofluorescent evidence of immune complexes, changes in the levels of the third component of complement, or the rectal temperature, and there was only a weak correlation with levels of C-reactive protein.
It remains to be seen whether these experiments provide an adequate model of infectionenhanced injury, and if so whether there is a common mechanism which will explain all the clinical observations. It is possible that this phenomenon is not restricted to patients with immunologically-mediated disease, since there are reports of both viral (Briggs et al. 1972 , Lopez et al. 1973 ) and bacterial (Byrd et al. 1978 ) enhanced rejection of renal transplants, and suggestions that graft-versus-host disease in bone marrow transplantation may also be precipitated by infection (E Gordon-Smith, personal communication 1982) .
Conclusion
This review has sought to highlight the complex relationship between infection and immunosuppression in patients with underlying immunologically-mediated disease. Although many of the lessons learnt about infection in leukaemia and organ transplantation can be extrapolated to this group, there are several unique features which may influence both the nature of and the response to infection, and these require further study.
